Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA.

A custom 30-gene melanoma sequencing panel for plasma ctDNA was tested in a cohort of 74 samples, covering driver mutations and alterations linked to treatment resistance.

CancersPubMed 32785074DOI 10.3390/cancers12082228